...
bpth-img

Bio Path Holdings Inc, Common Stock

BPTH

NAQ

$1.49

+$0.82

(122.57%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$2.88M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
113.40M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.22
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.59 L
$12 H
$1.49

About Bio Path Holdings Inc, Common Stock

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing BP1001-A that is in Phase I clinical trial for the treatment of solid tumors; Liposomal Bcl-2 (BP1002), which is in Phase I clinical trial for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; and Liposomal STAT3 (BP1003) for treating pancreatic cancer, non-small cell lung cancer, and AML. The company was founded in 2007 and is based in Bellaire, Texas. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameBPTHSectorS&P500
1-Week Return112.71%-3.35%-2.97%
1-Month Return86.48%-3.49%-0.66%
3-Month Return55.1%-12.6%2.71%
6-Month Return-35.22%-6.91%7.21%
1-Year Return-83.8%1.19%23.04%
3-Year Return-98.23%-0.21%28.43%
5-Year Return-99.02%33.09%82.88%
10-Year Return-99.99%93.55%184.63%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue230.00K151.00K161.00K178.00K178.00K[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":65.65,"profit":true},{"date":"2021-12-31","value":70,"profit":true},{"date":"2022-12-31","value":77.39,"profit":true},{"date":"2023-12-31","value":77.39,"profit":true}]
Gross Profit(230.00K)(151.00K)(161.00K)(178.00K)(178.00K)[{"date":"2019-12-31","value":-23000000,"profit":false},{"date":"2020-12-31","value":-15100000,"profit":false},{"date":"2021-12-31","value":-16100000,"profit":false},{"date":"2022-12-31","value":-17800000,"profit":false},{"date":"2023-12-31","value":-17800000,"profit":false}]
Gross Margin-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses8.69M10.91M10.44M13.90M15.84M[{"date":"2019-12-31","value":54.87,"profit":true},{"date":"2020-12-31","value":68.85,"profit":true},{"date":"2021-12-31","value":65.92,"profit":true},{"date":"2022-12-31","value":87.74,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(8.69M)(10.91M)(10.44M)(13.90M)(15.84M)[{"date":"2019-12-31","value":-869300000,"profit":false},{"date":"2020-12-31","value":-1090800000,"profit":false},{"date":"2021-12-31","value":-1044300000,"profit":false},{"date":"2022-12-31","value":-1390100000,"profit":false},{"date":"2023-12-31","value":-1584300000,"profit":false}]
Total Non-Operating Income/Expense188.00K52.00K6.00K66.00K(183.00K)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":27.66,"profit":true},{"date":"2021-12-31","value":3.19,"profit":true},{"date":"2022-12-31","value":35.11,"profit":true},{"date":"2023-12-31","value":-97.34,"profit":false}]
Pre-Tax Income(8.60M)(10.88M)(10.44M)(13.87M)(16.08M)[{"date":"2019-12-31","value":-859900000,"profit":false},{"date":"2020-12-31","value":-1088200000,"profit":false},{"date":"2021-12-31","value":-1044000000,"profit":false},{"date":"2022-12-31","value":-1386800000,"profit":false},{"date":"2023-12-31","value":-1607800000,"profit":false}]
Income Taxes(94.00K)(26.00K)(3.00K)(33.00K)-[{"date":"2019-12-31","value":-9400000,"profit":false},{"date":"2020-12-31","value":-2600000,"profit":false},{"date":"2021-12-31","value":-300000,"profit":false},{"date":"2022-12-31","value":-3300000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes(8.51M)(10.86M)(10.44M)(13.84M)-[{"date":"2019-12-31","value":-850500000,"profit":false},{"date":"2020-12-31","value":-1085600000,"profit":false},{"date":"2021-12-31","value":-1043700000,"profit":false},{"date":"2022-12-31","value":-1383500000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations(8.60M)(10.88M)(10.44M)(13.87M)(16.67M)[{"date":"2019-12-31","value":-859900000,"profit":false},{"date":"2020-12-31","value":-1088200000,"profit":false},{"date":"2021-12-31","value":-1044000000,"profit":false},{"date":"2022-12-31","value":-1386800000,"profit":false},{"date":"2023-12-31","value":-1667200000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(8.51M)(10.86M)(10.44M)(13.84M)(16.08M)[{"date":"2019-12-31","value":-850500000,"profit":false},{"date":"2020-12-31","value":-1085600000,"profit":false},{"date":"2021-12-31","value":-1043700000,"profit":false},{"date":"2022-12-31","value":-1383500000,"profit":false},{"date":"2023-12-31","value":-1607800000,"profit":false}]
EPS (Diluted)(3.27)(2.82)(1.57)(1.90)(8.56)[{"date":"2019-12-31","value":-327,"profit":false},{"date":"2020-12-31","value":-282,"profit":false},{"date":"2021-12-31","value":-157,"profit":false},{"date":"2022-12-31","value":-190,"profit":false},{"date":"2023-12-31","value":-856,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

BPTH
Cash Ratio 0.17
Current Ratio 0.86

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

BPTH
ROA (LTM) -140.03%
ROE (LTM) -366.18%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

BPTH
Debt Ratio Lower is generally better. Negative is bad. 1.24
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.24

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

BPTH
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 2.33
Price/FCF NM
EV/R 0.00
EV/Ebitda 0.03
PEG NM

FAQs

What is Bio Path Holdings Inc share price today?

Bio Path Holdings Inc (BPTH) share price today is $1.49

Can Indians buy Bio Path Holdings Inc shares?

Yes, Indians can buy shares of Bio Path Holdings Inc (BPTH) on Vested. To buy Bio Path Holdings Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BPTH stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Bio Path Holdings Inc be purchased?

Yes, you can purchase fractional shares of Bio Path Holdings Inc (BPTH) via the Vested app. You can start investing in Bio Path Holdings Inc (BPTH) with a minimum investment of $1.

How to invest in Bio Path Holdings Inc shares from India?

You can invest in shares of Bio Path Holdings Inc (BPTH) via Vested in three simple steps:

  • Click on Sign Up or Invest in BPTH stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Bio Path Holdings Inc shares
What is Bio Path Holdings Inc 52-week high and low stock price?

The 52-week high price of Bio Path Holdings Inc (BPTH) is $12. The 52-week low price of Bio Path Holdings Inc (BPTH) is $0.59.

What is Bio Path Holdings Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Bio Path Holdings Inc (BPTH) is

What is Bio Path Holdings Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Bio Path Holdings Inc (BPTH) is 2.33

What is Bio Path Holdings Inc dividend yield?

The dividend yield of Bio Path Holdings Inc (BPTH) is 0.00%

What is the Market Cap of Bio Path Holdings Inc?

The market capitalization of Bio Path Holdings Inc (BPTH) is $2.88M

What is Bio Path Holdings Inc’s stock symbol?

The stock symbol (or ticker) of Bio Path Holdings Inc is BPTH

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top